JUVANTIA PHARMA
Juvantia Pharma is discovers and develops pharmaceutical products for neurological and cardiovascular disorders. The company focuses on small molecule pharmaceuticals active on G-protein coupled receptors.
JUVANTIA PHARMA
Industry:
Biotechnology Manufacturing Pharmaceutical
Founded:
1997-01-01
Address:
Turku, Western Finland, Finland
Country:
Finland
Status:
Active
Contact:
+358 2651 71500
Total Funding:
0
Similar Organizations
Cardoz
Cardoz AB, based in Stockholm, Sweden, manufactures anti-inflammatory pharmaceuticals to combat heart and vascular disorders.
Insud Pharma
Insud Pharma is a company providing pharmaceutical solutions for the entire life cycle of a medicine.
Ipsen Pharma SA
Ipsen Pharma SA develops pharmaceutical products for oncology, endocrinology, and neuromuscular, gastroenterology.
Investors List
Aboa Venture Management
Aboa Venture Management investment in Venture Round - Juvantia Pharma
BioFund Management
BioFund Management investment in Venture Round - Juvantia Pharma
More informations about "Juvantia Pharma"
Juvantia Pharma - Crunchbase Company Profile & Funding
Juvantia Pharma has 2 investors including Aboa Venture Management and BioFund Management. When was the last funding round for Juvantia Pharma? Juvantia Pharma closed …See details»
Juvantia Pharma - Funding, Financials, Valuation & Investors
Juvantia Pharma has raised 1 round. This was a Venture - Series Unknown round raised on Sep 13, 2000. Juvantia Pharma is funded by 2 investors. Aboa Venture Management and BioFund …See details»
Juvantia Pharma - PitchBook
When was Juvantia Pharma founded? Juvantia Pharma was founded in 1997. Where is Juvantia Pharma headquartered? Juvantia Pharma is headquartered in Turku, Finland. What industry is …See details»
Santhera Acquires Juvantia and Secures All Rights to
Aug 17, 2009 In consideration and subject to certain conditions, Santhera Pharmaceuticals Holding AG will later issue up to 105,973 previously reserved shares from its authorized …See details»
Oy Juvantia Pharma Ltd. - Turku, Finland - bionity.com
Aug 17, 2009 Santhera Pharmaceuticals and Juvantia Pharma Ltd announced that the first patient has been enrolled into a Phase IIb clinical trial to evaluate JP-1730 ( ... Read news . 07 …See details»
Juvantia Pharma acquired by Santhera Pharmaceuticals - Crunchbase
Aug 17, 2009 Juvantia Pharma Juvantia Pharma is discovers and develops pharmaceutical products for neurological and cardiovascular disorders. Acquiring Organization: Santhera …See details»
Organization | Juvantia Pharma Ltd
Juvantia Pharma Ltd Report issue. For profit Phase 2. Founded: Turku Finland (1997) Status: Acquired by Santhera (2009 ...See details»
Juvantia Pharma Ltd. - BioCentury Company Profiles - BCIQ
Dec 13, 2010 Juvantia Pharma Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
Juvantia Pharma Oy - Drug pipelines, Patents, Clinical trials - Synapse
May 2, 2023 Explore Juvantia Pharma Oy with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, and 7 literature, Drug:Fipamezole Hydrochloride, JP-1302. Data. …See details»
Santhera Acquires Juvantia and Secures All Rights to JP …
Aug 17, 2009 Santhera Pharmaceuticals announced that it exercised its option to acquire Oy Juvantia Pharma Ltd of Turku, Finland, the owner of JP-1730/fipamezole. Santhera will issue …See details»
BioPharmaLink profile of Juvantia Pharma, Finland,
Juvantia Pharma: Juvantia is a Finnish pharmaceutical R&D company founded in April 1997. The first Product Concept of Juvantia is a novel adjunct to treatment of Parkinson's disease, …See details»
JUVANTIA PHARMA European Union Trademark Information
Nov 11, 2019 JUVANTIA PHARMA is a trademark and brand of Oy Juvantia Pharma Ltd., Turku 20520, FINLAND. This trademark was filed to EUIPO on Monday, January 11, 1999. The …See details»
Juvantia Pharma Oy (Juvantia Pharma Oy) - 药物管线_专利_临床试 …
了解Juvantia Pharma Oy (Juvantia Pharma Oy)公司的药物管线，治疗领域，技术平台，以及它的3项临床试验，药物:盐酸非帕美唑，JP-1302。See details»
Santhera Reports Closing of Juvantia Acquisition and Final Upfront ...
Oct 5, 2009 Santhera Pharmaceuticals announced the final closing of the acquisition of Oy Juvantia Pharma Ltd of Turku, Finland.Santhera issued 105,973 previously reserved shares …See details»
Juvantia Pharma - Crunchbase
Juvantia Pharma is discovers and develops pharmaceutical products for neurological and cardiovascular disorders. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. …See details»
Juvantia - Products, Competitors, Financials, Employees, …
Developer of pharmaceuticals for neurodegenerative diseases, mental disorders, and vascular wall disorders. Use the CB Insights Platform to explore Juvantia's full profile. Juvantia - …See details»
Patents Assigned to Oy Juvantia Pharma LTD
Sep 14, 2009 Assignee: Oy Juvantia Pharma Ltd. Inventors: Päivi Juujärvi, Seppo Parhi, Jaana Karjalainen Process for preparing substituted imidazole derivates and intermediates used in …See details»
Santhera buys Juvantia to get rights to Parkinson's drug ...
Aug 17, 2009 Swiss biotechnology firm Santhera Pharmaceuticals has entered into an agreement to gain rights to JP-1730/fipamezole from Finland-based Oy Juvantia Pharma, …See details»
Juvantia Pharma Oy - Drug pipelines, Patents, Clinical trials - Synapse
Clinical Trials associated with Juvantia Pharma Oy. NCT00758849 / Unknown status Phase 2. A Phase II, Randomised, Placebo-Controlled, Double-Blind, Replicated Crossover, Pilot Study …See details»
Santhera Picks Up Juvantia to Secure Full Rights to Candidate for ...
Aug 17, 2009 Santhera Pharmaceuticals is buying Finnish company OY Juvantia Pharma for its Parkinson’s disease therapeutic candidate, fipamezole (JP-1730). Santhera and Juvantia have …See details»